Trial Profile
A phase 2, randomized, double-blind, parallel-group, non-inferiority trial to evluate the safety and efficacy of isavuconazole with fluconazole in the treatment of uncomplicated esophageal candidiasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Nov 2015
Price :
$35
*
At a glance
- Drugs Fluconazole (Primary) ; Isavuconazole (Primary)
- Indications Candidiasis
- Focus Therapeutic Use
- 17 Nov 2015 New trial record